Top Markets
Coin of the day
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

FSNUY
Rang în acțiuni #183
Fresenius SE & Co. KGaA, a health care company, provides products and services... Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Preț acțiune
$12.65
Capitalizare de piață
$114.00B
Schimbare (1 zi)
1.36%
Schimbare (1 an)
3.52%
Țară
DE
Tranzacționează Fresenius SE & Co. KGaA (FSNUY)

Categorie

Raport P/E pentru Fresenius SE & Co. KGaA (FSNUY)
Raport P/E la data de July 2026 TTM: 15.42
Conform celor mai recente rapoarte financiare și prețului acțiunilor Fresenius SE & Co. KGaA, raportul P/E actual (TTM) este 15.42. La sfârșitul anului 2023, compania avea un P/E de -26.62.
Istoricul raportului P/E pentru Fresenius SE & Co. KGaA din 2002 până în 2026
Raportul P/E la sfârșitul fiecărui an
An Raport P/E Schimbă
2026 (TTM) 15.42 -61.55%
2024 40.11 -250.69%
2023 -26.62 -347.86%
2022 10.74 -1.18%
2021 10.87 -12.06%
2020 12.36 -16.72%
2019 14.84 25.16%
2018 11.86 -40.46%
2017 19.91 -21.96%
2016 25.52 -3.60%
2015 26.47 20.88%
2014 21.90 10.82%
2013 19.76 21.32%
2012 16.29 85.50%
2011 8.78 4.03%
2010 8.44 19.22%
2009 7.08 -66.62%
2008 21.21 0.48%
2007 21.10 -10.70%
2006 23.63 253.85%
2005 6.68 10.06%
2004 6.07 -20.73%
2003 7.66 108.28%
2002 3.68 0.00%
Raportul P/E pentru companii similare sau concurenți
Companie P/E Ratio Diferență P/E Ratio Țara
12.43 -19.39%
US
31.92 107.01%
SA
9.47 -38.57%
US
19.33 25.36%
CN
22.90 48.48%
US
Cum interpretezi un P/E ratio?

Raportul Preț/Câștig (P/E Ratio) măsoară relația dintre prețul acțiunii unei companii și câștigul pe acțiune.
Un P/E scăzut dar pozitiv indică o companie cu profituri mari în raport cu evaluarea actuală și ar putea fi subevaluată. Un P/E negativ mare (aproape de 0) indică pierderi majore.

Companiile cu un P/E peste 30 sau negativ sunt considerate în general „acțiuni de creștere”, adică investitorii se așteaptă la creștere sau profitabilitate viitoare.

Companiile cu un P/E pozitiv sub 10 sunt considerate „acțiuni de valoare”, adică sunt deja profitabile, dar cu șanse mici de creștere suplimentară.